Hearing Loss Secondary to TECTA Gene Mutations.

Unidades

• CICLO CELULAR, CÉLULAS MADRE Y CÁNCER

  

  Investigador Responsable

  Alberto Gandarillas Solinis

• DIAGNÓSTICO Y TRATAMIENTO POR IMAGEN

  Investigador Responsable

  Elena Carmen Gallardo Agromayor

• SEÑALIZACIÓN CELULAR Y DIANAS TERAPÉUTICAS EN CÁNCER

  

  Investigador Responsable

  José Luis Fernández Luna

Abstract

OBJECTIVES: To assess the prevalence and clinical characterization of variants in the TECTA gene among individuals with bilateral sensorineural hearing loss of unknown etiology in northern Spain. METHODS: A 6-year (2018-2024) observational, prospective, and descriptive study was conducted on patients with bilateral sensorineural hearing loss at a tertiary hospital. Next generation sequencing using a gene panel for sensorineural hearing loss was performed to detect pathogenic, likely pathogenic, or variants of unknown significance in the TECTA gene. RESULTS: Among 326 patients, pathogenic or likely pathogenic TECTA variants were found in 7 patients (2.14%), including c.3107G>A (n = 6) and c.5383+6T>A (n = 1). Variants of unknown significance were found in 8 patients (2.45%). About 14 of 15 probands had a family history of hearing loss with autosomal dominant inheritance. Eight relatives with confirmed pathogenic variants were also included, totalling 23 cases. Six patients with pathogenic variants and 3 with variants of unknown significance had moderate mid-frequency hearing loss, while others had severe high-frequency loss. Hearing loss was typically progressive, ranging from congenital onset to the fifth decade. Most were treated with hearing aids; none required cochlear implants. CONCLUSIONS: TECTA gene variants are relatively common in this population, with c.3107G>A being the most frequent. The typical phenotype is slowly progressive, mid-to-high frequency sensorineural hearing loss, often starting in childhood and usually requiring hearing aids fitting with good results in improving speech intelligibility.

Keywords

• TECTA gene; audiology; genetics; non-syndromic hearing loss; sensorineural hearing loss